A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).
Existing drug alleviates symptoms of a rare genetic syndrome
- Post author:
- Post published:May 30, 2024
- Post category:uncategorized